A Phase 2 Randomized, Human Growth Hormone-controlled, multicenter Basket study of Vosoritide in Children with Turner Syndrome, Short Stature Homeobox-containing Gene Deficiency, and Noonan Syndrome with and inadequate response to Human Growth Hormone.

Clinical Topic

Age Range

• 4-10 years

Sex

• Studies with Male Participants